Mitophagy and Mitochondrial DNA Dynamics During Ramadan Dry Fasting vs 16:8 Time-Restricted Feeding (MITO FAST)
Mitophagic Flux and Mitochondrial DNA Dynamics During Circadian-Aligned Ramadan Dry Fasting Versus 16:8 Time-Restricted Feeding: A Four-Phase Translational Research Programme
This study investigates how different types of fasting affect cell health, specifically focusing on how mitochondria (the energy-producing parts of cells) are cleared and renewed. While standard intermittent fasting allows water intake, Ramadan dry fasting involves total restriction of both food and fluids from dawn to sunset.
Researchers want to see if the combined effects of fluid restriction and natural daily body rhythms during Ramadan trigger a stronger cellular cleanup process (called mitophagy) compared to standard 16:8 water-permitted fasting. The study will look at how these fasting habits change blood markers related to mitochondrial DNA and metabolic health across a 30-day period. This research will help determine if dry fasting offers distinct biological benefits for cellular renewal.
調査の概要
状態
詳細な説明
This is a prospective, single-centre, parallel-group, longitudinal observational cohort study conducted across Ramadan 2027. The study aims to evaluate the distinct molecular and metabolic trajectories of intermittent dry fasting compared to standard fluid-permitted time-restricted feeding (TRF).
Participants will be allocated to one of two parallel groups based on their self-selected, established fasting practices:
- Group A (Ramadan Dry Fasting): Observing complete fluid and nutrient deprivation from dawn (Fajr) to sunset (Maghrib) for 30 consecutive days.
- Group B (16:8 TRF): Practicing a 16-hour daily fasting window with water/fluids permitted, observed concurrently during the same calendar period.
Participants in both groups will be pairwise-matched based on age and BMI at screening. Blood samples will be collected from all participants at five distinct milestones:
- T0: Pre-Ramadan baseline (Day -3)
- T1: Acute induction phase (Day 7)
- T2: Mitochondrial turnover phase (Day 14)
- T3: Saturation plateau / primary endpoint (Day 30)
- T4: Post-Ramadan recovery phase (Day 44)
Peripheral blood mononuclear cells (PBMCs) and serum will be isolated from the collected blood. Laboratory analyses will measure mitochondrial DNA (mtDNA) copy number changes via qPCR, alongside a quantitative gene expression panel evaluating key regulators of mitophagy (such as PINK1 and Parkin), mitochondrial biogenesis, and general autophagy. Secondary evaluations include routine serum metabolic indicators, inflammatory markers, and dietary monitoring to evaluate the physiological pathways predicted by computational systems pharmacology.
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前：Ibrahim Ibrahim Shuaibu, MD, Msc
- 電話番号：+905338730889
- メール：ibrahim.shuaibu@baucyprus.edu.tr
研究場所
-
-
-
Nicosia、キプロス
- Near East University
-
コンタクト：
- Berna Uzun, Prof.
- 電話番号：+90 533 871 98 38
- メール：berna.uzun@neu.edu.tr
-
副調査官：
- Adanze Cynthia Nge
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Common Criteria (Both Arms):
- Age 18-50 years
- BMI 18.5-30.0 kg/m²[cite: 1]
- Non-smoker for at least 12 months[cite: 1]
- No chronic disease requiring regular prescription medication[cite: 1]
- Stable sleep-wake schedule (self-reported sleep midpoint deviation less than 90 minutes)[cite: 1]
- Willing and able to attend all five study visits at the specified times[cite: 1]
Arm A Specific (Ramadan Dry Fasting):
- Documented religious commitment and intention to complete all 30 days of Ramadan 2027 fasting[cite: 1]
Arm B Specific (16:8 TRF Control):
- Confirmed practice of 16:8 TRF (fasting window 16 hours or more per day) throughout the study period[cite: 1]
- Not observing Ramadan dry fasting during the study period[cite: 1]
Exclusion Criteria:
- Established type 1 or type 2 diabetes (HbA1c 6.5% or higher or pharmacological antidiabetic therapy)[cite: 1]
- Severe gastrointestinal, cardiovascular, hepatic, or renal disease (eGFR less than 60 mL/min/1.73m²)[cite: 1]
- Active cancer or chemotherapy within five years[cite: 1]
- Use of metformin, statins, or exogenous antioxidant supplements (vitamins C, E, NAC, CoQ10) within 30 days of screening[cite: 1]
- Pregnancy, lactation, or planned conception during the study period[cite: 1]
- Participation in another clinical study within three months[cite: 1]
- Inability to provide written informed consent in Arabic or English[cite: 1]
研究計画
研究はどのように設計されていますか？
デザインの詳細
コホートと介入
グループ/コホート |
介入・治療 |
|---|---|
|
Arm A: Ramadan Dry Fasting
Participants observing complete, daily fluid and nutrient deprivation from dawn (Fajr) to sunset (Maghrib) for 30 consecutive days during Ramadan 2027
|
Total fluid and nutrient restriction enforced daily from dawn (Fajr) to sunset (Maghrib) for 30 consecutive days.
Food and fluid consumption are restricted to the nocturnal period
|
|
Arm B: 16:8 Time-Restricted Feeding
Pairwise-matched control participants practicing a fluid-permitted, 16-hour daily fasting window observed concurrently during the same calendar period
|
A 16-hour daily fasting window where calorie-containing foods and beverages are completely restricted.
Fluid intake (such as water or uncaloried drinks) is permitted throughout the fasting period
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Between-arm difference in PINK1 and Parkin mitophagy gene expression
時間枠：Change from baseline (Day -3) to Day 30 of the fasting period
|
Relative expression levels of PINK1 and Parkin mRNA will be quantified via probe-based quantitative reverse transcription PCR (qRT-PCR) from isolated peripheral blood mononuclear cells (PBMCs).
Normalization will be performed using the geometric mean of housekeeping genes GAPDH and B2M.
Evaluation will focus on the between-arm contrast (Arm A vs. Arm B) of the change metric using relative quantification (2^-ΔΔCt).
|
Change from baseline (Day -3) to Day 30 of the fasting period
|
|
Between-arm difference in mitochondrial DNA copy number (mtCN)
時間枠：Change from baseline (Day -3) to Day 30 of the fasting period
|
Mitochondrial DNA copy number will be quantified by qPCR targeting the mitochondrial reference region MT-RNR1 (12S rRNA), normalized to the nuclear reference gene B2M.
Relative mtCN is calculated using the formula: 2 × (Ct_nuclear - Ct_mtDNA).
The primary evaluation is the between-arm difference in net change at Day 30 to test for a predicted U-shaped cellular trajectory
|
Change from baseline (Day -3) to Day 30 of the fasting period
|
協力者と研究者
捜査官
- スタディチェア：Berna Uzun、Operational Research Institute in Healthcare, Near East University, Nicosia, TRNC, Mersin 10, Turkey
出版物と役立つリンク
一般刊行物
- Sarkar B, Hajra A. Hydro-phosphorothiolation of Styrene and Cyclopropane with S-Hydrogen Phosphorothioates under Ambient Conditions. Org Lett. 2024 Jun 21;26(24):5141-5145. doi: 10.1021/acs.orglett.4c01586. Epub 2024 Jun 7.
- Dillard J, Meng X, Nelin L, Liu Y, Chen B. Nitric oxide activates AMPK by modulating PDE3A in human pulmonary artery smooth muscle cells. Physiol Rep. 2020 Sep;8(17):e14559. doi: 10.14814/phy2.14559.
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- Bahcesehir Cyprus University
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
IPD 共有サポート情報タイプ
- STUDY_PROTOCOL
- SAP
- CSR
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。